首页> 外文期刊>European urology >Re: Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population
【24h】

Re: Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population

机译:回复:前列腺癌的长期预测:前列腺特异性抗原(PSA)速度是可预测的,但并不能提高大的,代表性的,未经筛查的人群进行癌症诊断前15年或更长时间的单个PSA测量的预测准确性。

获取原文
获取原文并翻译 | 示例
       

摘要

Experts' summary:Ulmert et al reported on prostate-specific antigen velocity (PSAV) in 4907 men from a preventive medicine study with two blood draws approximately 6 yr apart. The 20-yr probability of prostate cancer (PCa) diagnosis was strikingly different for men with a PSAV in the 50th percentile versus the 95th percen-tile (9.1% vs 14.1%). On receiver operating characteristic (ROC) analysis, however, the concordance index (c-index) for PCa diagnosis was 0.771 using prostate-specific antigen (PSA) alone and with the addition of PSAV. To predict advanced disease, adding PSAV to PSA increased the c-index marginally from 0.848 to 0.849.
机译:专家总结:Ulmert等人通过一项预防医学研究报告了4907名男性的前列腺特异性抗原速度(PSAV),两次抽血相距约6年。患有PSAV的男性在50%和95%之间的20年前列腺癌(PCa)诊断概率显着不同(9.1%对14.1%)。然而,在接受者工作特征(ROC)分析中,仅使用前列腺特异性抗原(PSA)并添加PSAV,诊断PCa的一致性指数(c-index)为0.771。为了预测晚期疾病,在PSA中添加PSAV会使c指数从0.848略微增加到0.849。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号